126 related articles for article (PubMed ID: 8587164)
41. Ticarcillin and ticarcillin-clavulanic acid susceptibility tests: error rates for disk tests with consecutively isolated members of the family Enterobacteriaceae.
Barry AL; Fuchs PC; Gerlach EH; Hardy DJ; McLaughlin JC; Pfaller MA
Antimicrob Agents Chemother; 1992 Jan; 36(1):137-43. PubMed ID: 1590679
[TBL] [Abstract][Full Text] [Related]
42. Piperacillin/tazobactam and ticarcillin/clavulanic acid against resistant Enterobacteriaceae.
Kempers J; MacLaren DM
J Antimicrob Chemother; 1990 Oct; 26(4):598-9. PubMed ID: 2174855
[No Abstract] [Full Text] [Related]
43. [Resistance to amoxicillin and amoxicillin-clavulanic acid combination of 231 clinical strains of Escherichia coli, isolated in 1992 at the Cochin Hospital].
Bémer-Melchior P; Gilly L; Jugroot-Klotz K; Brun T; Névot P; Paul G
Pathol Biol (Paris); 1995 Nov; 43(9):760-5. PubMed ID: 8746097
[TBL] [Abstract][Full Text] [Related]
44. Activity of clavulanate combinations against TEM-1 beta-lactamase-producing Escherichia coli isolates obtained in 1982 and 1989.
Seetulsingh PS; Hall LM; Livermore DM
J Antimicrob Chemother; 1991 Jun; 27(6):749-59. PubMed ID: 1938685
[TBL] [Abstract][Full Text] [Related]
45. Antibacterial effects of ticarcillin/clavulanic acid in animal models of infection.
Boon RJ; Beale AS; Sutherland R
J Antimicrob Chemother; 1986 May; 17 Suppl C():41-6. PubMed ID: 3087934
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of 500 gram negative isolates to determine the number of major susceptibility interpretation discrepancies between the Vitek and MicroScan Walkaway for 9 antimicrobial agents.
Rittenhouse SF; Miller LA; Utrup LJ; Poupard JA
Diagn Microbiol Infect Dis; 1996 Sep; 26(1):1-6. PubMed ID: 8950521
[TBL] [Abstract][Full Text] [Related]
47. Effect of ticarcillin and ticarcillin/clavulanic acid on the in-vitro activity of human granulocytes against beta-lactamase-producing Klebsiella pneumoniae.
Cuffini AM; de Renzi G; Tullio V; Paizis G; Carlone NA
Int J Tissue React; 1995; 17(5-6):199-203. PubMed ID: 8835630
[TBL] [Abstract][Full Text] [Related]
48. [Antimicrobial activities of gentamicin against fresh clinical isolates].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K; Fukumoto T
Jpn J Antibiot; 1990 Oct; 43(10):1674-84. PubMed ID: 2128340
[TBL] [Abstract][Full Text] [Related]
49. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
[TBL] [Abstract][Full Text] [Related]
50. [Combinations of beta-lactamase inhibitors and semisynthetic penicillins: amoxycillin/clavulanic acid (augmentin, amox-clav ), thycarcillin/clavulanic acid (thymentin). Action and usage].
Fomina IP
Antibiot Khimioter; 1997; 42(12):29-32. PubMed ID: 9480651
[No Abstract] [Full Text] [Related]
51. Reassessment of susceptibility test interpretive criteria for ticarcillin and ticarcillin-clavulanic acid.
Fuchs PC; Jones RN; Barry AL
J Clin Microbiol; 1989 Nov; 27(11):2475-81. PubMed ID: 2808671
[TBL] [Abstract][Full Text] [Related]
52. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
Sader HS; Tosin I; Sejas L; Miranda E
Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
[TBL] [Abstract][Full Text] [Related]
53. Potential effects of amoxycillin/clavulanic acid and ticarcillin/clavulanic acid on human granulocyte activity: a comparative study.
Cuffini AM; Tullio V; Paizis G; Carlone NA
J Antimicrob Chemother; 1996 Dec; 38(6):1013-22. PubMed ID: 9023648
[TBL] [Abstract][Full Text] [Related]
54. Comparison of in vitro activity of cefotaxime and desacetylcefotaxime alone and in combination against 320 gram-negative clinical isolates.
Piédrola G; Galan I; Leyva A; Maroto MC
Drugs; 1988; 35 Suppl 2():62-4. PubMed ID: 3135171
[TBL] [Abstract][Full Text] [Related]
55. [Comparative study of a combination of amoxicillin and clavulanic acid and a combination of ticarcillin and clavulanic acid on 249 enterobacteria].
Aubert G; Lallard P; Dorche G; Denis M
Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):651-4. PubMed ID: 3054741
[TBL] [Abstract][Full Text] [Related]
56. In vitro anaerobic data on ticarcillin/clavulanate. A review of an ongoing survey.
Sanders CV; Aldridge KE
J Reprod Med; 1990 Mar; 35(3 Suppl):313-6. PubMed ID: 2319513
[TBL] [Abstract][Full Text] [Related]
57. In vitro susceptibility of piperacillin v timentin and ticarcillin.
Bremner DA
N Z Med J; 1987 May; 100(823):299-300. PubMed ID: 3138579
[No Abstract] [Full Text] [Related]
58. [New antimicrobial agent series XXXVII: potassium clavulanate/Ticarcillin sodium].
Fujimori I
Jpn J Antibiot; 1991 Apr; 44(4):365-87. PubMed ID: 1880918
[No Abstract] [Full Text] [Related]
59. Antibacterial activities of amoxicillin alone and in combination with clavulanic acid correlated with beta-lactamase production.
Hsu LY; Chang SC; Luh KT; Hsieh WC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):272-80. PubMed ID: 1818798
[TBL] [Abstract][Full Text] [Related]
60. Ticarcillin/clavulanate in the treatment of pelvic infections.
Lucas MJ; Cox SM; Roark ML; Cunningham FG
J Reprod Med; 1990 Mar; 35(3 Suppl):343-7. PubMed ID: 2181121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
